Proposal to list a range of personal protective equipment from multiple suppliers
What we’re proposing
Pharmac is seeking feedback on a proposal to enter into medical device listing agreements from 1 April 2026 with the following suppliers:
- Global Medics Limited
- Gravity Trading Limited
- Jackson Allison Medical & Surgical Limited
- Mediscope International Limited
- Mun (New Zealand) Limited
- Paragon Care Group New Zealand Limited
- Reynard Health Supplies Ltd
- SPQ Limited
- Tamaki Group Limited
- Universal Specialties Limited
- Westlab (NZ) Limited Partnership
Medical devices proposed for listing are in the following personal protective equipment (PPE) sub-categories:
- Gowns and Aprons
- Aprons
- Coveralls (Type 5 and 6)
- Isolation/Protective Gowns
- Masks
- Procedure Masks
- Surgical Masks (Level 3 with head ties)
- Surgical Masks with Visor (Level 3 with head ties)
Consultation closes at 4pm Thursday 26 February 2026 and feedback can be emailed to Sam.Edlund@Pharmac.govt.nz
What would the effect be?
From 1 April 2026, medical devices supplied by the named suppliers above would be listed under proposed national agreements for Health New Zealand | Te Whatu Ora (“Health NZ”) to purchase under, subject to consultation and approval by Pharmac’s Board or delegate (“Agreements”).
The Agreements would not be for sole supply. Suppliers’ brands would be listed on the Pharmaceutical Schedule under the terms of a restricted open panel where Health NZ would purchase the relevant devices from the suppliers listed under each sub-category. Being a restricted open panel means that Pharmac or Health NZ may, in response to market dynamics and other criteria at its sole discretion, provide opportunities during the term of the Panel, for new suppliers to join.
The Agreements would supersede any existing Health NZ contracts with the listed suppliers for the products included in the Agreement. Any medical devices listed in the Agreement and purchased by Health NZ would be in accordance with the terms and conditions, including price, stated in the Agreement effective from the date of listing on the Pharmaceutical Schedule.
Pricing for the medical devices in the Agreement, subject to any prior termination of the Agreement, would not be increased without prior consultation and approval by Pharmac.
Who we think will be interested
- Health NZ staff in a range of different operational and clinical settings but not limited to:
- Clinical product management
- Emergency management
- General ward staff
- Haematology/oncology
- Infection prevention and control
- Laboratory staff
- Occupational health and safety
- Operating theatre nurses
- Procurement and supply chain
- Supplier and wholesalers
About these medical devices
PPE refers to protective clothing or other garments or equipment designed to protect the wearer’s body from injury or infection. The hazards addressed by PPE includes physical, electrical, heat, chemicals, biohazards and airborne particulate matter.
Why we’re proposing this
Pharmac, in conjunction with Health NZ, initially released a PPE Registration of Interest (ROI) in May 2024. Following the ROI, successful suppliers were invited to the closed Request for Proposals (RFP) for the subcategories “Gowns and Aprons” and “Masks”
- Supply of Gowns, Aprons and Masks in January 2025
- Supply of Isolation/Protective Gowns in March 2025
The RFPs were for non-exclusive national agreements for listing on the Pharmaceutical Schedule under the terms of a restricted open panel of suppliers.
Pharmac has been working with suppliers who responded to the RFPs and were successful in being progressed to contract negotiation to seek provisional agreements. This proposal consists of the agreements to arise from this process.
All devices proposed for listing have been deemed as clinically suitable by the PPE Expert Advisory Group.
Details about our proposal
Pharmac has entered into agreements with the 11 suppliers for the supply of PPE. The proposal would result in listing 56 medical devices in the PPE category on the Pharmaceutical Schedule.
A summary of each supplier’s devices and brand name can be found in the table below:
|
Supplier: |
Brand Names: |
|---|---|
|
Global Medics Limited |
Incontrol |
|
Gravity Trading Limited |
1H |
|
Jackson Allison Medical & Surgical Limited |
Nanjing Jackson Allison |
|
Mediscope International Limited |
Leboo |
|
Mun (New Zealand) Limited |
PrimeOn |
|
Paragon Care Group New Zealand Limited |
Baremedical |
|
Reynard Health Supplies Ltd |
Reynard |
|
SPQ Limited |
ADVANCE |
|
Tamaki Group Limited |
TGL |
|
Universal Specialties Limited |
USL Medical |
|
Westlab (NZ) Limited Partnership |
Westlab |
Further information, including pricing and contractual details, have been provided to Health NZ procurement personnel. Clinicians interested in further detail on what this change means should engage with their Health NZ procurement contacts.
To provide feedback
Send us an email: Sam.Edlund@Pharmac.govt.nz by 4pm Thursday 26 February 2026.
All feedback received before the closing date will be considered by Pharmac’s Board (or its delegate) prior to making a decision on this proposal.
Your feedback may be shared
When you give feedback on a consultation, your feedback becomes official information that Pharmac holds. Pharmac has legal responsibilities for how we manage this official information, under laws such as the Official Information Act and Privacy Act.
Pharmac may receive a request from people for official information, which could include your feedback. Legally, Pharmac must consider whether your feedback should be released.
We will consider your views when assessing whether the feedback has to be released. Tell us if there is anything about your feedback that you would prefer wasn’t released.
If your feedback is proposed for release, then Pharmac will contact you, unless there is a legal reason that we can't.
Note that Pharmac collects and holds your information in line with our Privacy Statement.